Respiratory syncytial virus: virology, reverse genetics, and pathogenesis of disease.
about
Initiation and regulation of paramyxovirus transcription and replicationViral Infection in the Development and Progression of Pediatric Acute Respiratory Distress SyndromeAnalysis of Human RSV Immunity at the Molecular Level: Learning from the Past and PresentA comprehensive proteomic view of responses of A549 type II alveolar epithelial cells to human respiratory syncytial virus infectionNovel antigens for RSV vaccines.Priming of the Respiratory Tract with Immunobiotic Lactobacillus plantarum Limits Infection of Alveolar Macrophages with Recombinant Pneumonia Virus of Mice (rK2-PVM)The Interferon Type I/III Response to Respiratory Syncytial Virus Infection in Airway Epithelial Cells Can Be Attenuated or Amplified by Antiviral TreatmentInvestigating the Influence of Ribavirin on Human Respiratory Syncytial Virus RNA Synthesis by Using a High-Resolution Transcriptome Sequencing Approach.Respiratory Syncytial Virus whole-genome sequencing identifies convergent evolution of sequence duplication in the C-terminus of the G gene.Vaccines against respiratory syncytial virus: The time has finally come.Novel diversity-oriented synthesis-derived respiratory syncytial virus inhibitors identified via a high throughput replicon-based screen.Immunological Features of Respiratory Syncytial Virus-Caused Pneumonia-Implications for Vaccine DesignReverse genetics of Mononegavirales: How they work, new vaccines, and new cancer therapeuticsCD4+ T cells support establishment of RSV-specific IgG and IgA antibody secreting cells in the upper and lower murine respiratory tract following RSV infection.Mechanism of action for respiratory syncytial virus inhibitor RSV604.Characterization of a respiratory syncytial virus L protein inhibitor.Neutralizing epitopes of RSV and palivizumab resistance in Japan.A three-dimensional model of human lung development and disease from pluripotent stem cells.Decapping protein 1 phosphorylation modulates IL-8 expression during respiratory syncytial virus infection.Respiratory Syncytial Virus Inhibitor AZ-27 Differentially Inhibits Different Polymerase Activities at the PromoterRSV vaccine: Beating the virus at its own game.Dynamic changes in the CD4 T cell transcriptome are associated with disease severity during primary RSV infection in young infants.Respiratory syncytial virus genotypes NA1, ON1, and BA9 are prevalent in Thailand, 2012-2015.Structural basis of respiratory syncytial virus subtype-dependent neutralization by an antibody targeting the fusion glycoprotein.Adjuvants and the vaccine response to the DS-Cav1-stabilized fusion glycoprotein of respiratory syncytial virus.A Two-Dimensional Human Minilung System (Model) for Respiratory Syncytial Virus Infections.A Built-In CpG Adjuvant in RSV F Protein DNA Vaccine Drives a Th1 Polarized and Enhanced Protective Immune Response.Differential responses by human respiratory epithelial cell lines to respiratory syncytial virus reflect distinct patterns of infection control.
P2860
Q26851684-E05C4BB2-C561-4977-9157-247EC1C049CDQ28071857-7C1C64B5-F6D5-42C8-AF48-66FC4459AE9EQ28080556-3C83D1AB-5D4C-4C22-BF4D-0647B84A8AD8Q34634867-BBDB8445-C39E-4B65-BE57-45D71B8A346DQ36005960-8CE5A979-0C1E-4295-8DC7-076AB05C5341Q36434174-CE53E7E3-E4B7-47B2-9A35-628D0761F059Q36523926-03C89C84-1C50-4B34-81DE-44CB59412E3AQ36878963-89CCFDC0-8BA0-4851-AD66-6894944416F6Q36925097-9B7C09E7-931C-440E-B51D-4A991453DE0BQ37018347-3C8923A3-D969-497D-B9F1-45A694AA7C71Q37077580-30FEC06F-358C-4A2A-B9CA-552BFC4160B2Q37729137-457F276F-3707-4250-B9EF-2A3590559930Q38363535-3CD96F00-E181-4A7B-8595-98939A6C74DAQ38836417-6E5AD55C-748C-4CB6-89CA-2C2861E779ADQ38934645-C918CC45-5169-4A20-9168-E8190A8250D1Q39000655-D19F979C-BA75-431E-B613-7F500C2FB275Q40059727-590B64BA-504B-42C8-8F47-606CF088316BQ40230465-B2EBFA45-D345-4896-AEE9-067DAFE35480Q40856542-8679C7BE-1029-4245-8819-57F20183F748Q40917488-5395C0E6-D511-4631-8A82-F2A09E660E99Q41149828-23D36047-DB76-472A-B127-755B2D1EE19BQ41927812-4C351725-B465-43E0-99B0-542619981659Q42978263-676387E4-B88F-4B5D-9859-BE5AC1328F8BQ45324052-A787D9CD-4118-4544-9A96-175E846DB1D9Q45325639-6F470C33-58D0-4FAA-AFD7-CA2D0262AC63Q47123496-E0A3EA2A-F76E-4271-B357-FA466ABEA4A2Q47552388-4189EDBE-F244-4C97-A736-398C2F09868EQ54209631-21494533-69DA-44D4-BBA8-827AD0162107
P2860
Respiratory syncytial virus: virology, reverse genetics, and pathogenesis of disease.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Respiratory syncytial virus: virology, reverse genetics, and pathogenesis of disease.
@ast
Respiratory syncytial virus: virology, reverse genetics, and pathogenesis of disease.
@en
type
label
Respiratory syncytial virus: virology, reverse genetics, and pathogenesis of disease.
@ast
Respiratory syncytial virus: virology, reverse genetics, and pathogenesis of disease.
@en
prefLabel
Respiratory syncytial virus: virology, reverse genetics, and pathogenesis of disease.
@ast
Respiratory syncytial virus: virology, reverse genetics, and pathogenesis of disease.
@en
P2860
P1476
Respiratory syncytial virus: virology, reverse genetics, and pathogenesis of disease.
@en
P2093
Peter L Collins
Rachel Fearns
P2860
P356
10.1007/978-3-642-38919-1_1
P577
2013-01-01T00:00:00Z